Table 3.
All MS probands vs controls |
Sporadic MS vs controls |
Multiplex MS vs controls |
Sporadic MS vs multiplex MS |
|||||
---|---|---|---|---|---|---|---|---|
wGRS based on | AUC | 95% CI | AUC | 95% CI | AUC | 95% CI | AUC | 95% CI |
HLA-DRB1*1501 | 0.63 | 0.61–0.66 | 0.60 | 0.57–0.63 | 0.68 | 0.65–0.72 | 0.58 | 0.55–0.63 |
102 non-HLA SNPs | 0.66 | 0.63–0.68 | 0.64 | 0.60–0.67 | 0.69 | 0.65–0.73 | 0.55 | 0.49–0.60 |
102 non-HLA SNPs | ||||||||
+HLA-DRB1*1501 | 0.72 | 0.69–0.75 | 0.69 | 66–0.72 | 0.77 | 0.73–0.81 | 0.61 | 0.55–0.66 |
MS: multiple sclerosis; wGRS: weighted genetic risk score; AUC: area under the receiver operating curve; CI: confidence interval; HLA: human leukocyte antigen; SNP: single nucleotide polymorphism.